Dealt Ltd (ASX: DET) has been established in response to the emergence of private, non-bank lenders in the $302 billion Australian and New Zealand Commercial Real Estate (CRE) lending market to provide alternative lending sources for borrowers. The Group’s objective is to achieve a 6% return via diversified business that will specialise in Commercial Real Estate (CRE) Debt Brokerage and Advisory, Lending and Funds Management.
Dealt has developed one of Australia’s first real time CRE finance marketplaces to assist borrowers secure non-bank finance. The Group will also look to drive secure income returns through the development of a diversified portfolio of secured commercial real estate loans across Australia and New Zealand.
The COVID-19 pandemic has caused a wave of discounted capital raisings with ~$53 billion of discounted new shares issued in the last 12 months.
Share Purchase Plans (SPPs) allow individual shareholders to apply for up to $30,000 in shares at the same discounted price paid by institutions. In the 12 months to 31 December, in-the-money SPPs were issued at an average 10% discount to the ASX closing price on the SPP closing date. But, you must be a shareholder before the SPP is announced.
SPP HarvesterTM gives you access to SPPs by buying you 1-share in 300 of the largest, liquid, operating companies listed on ASX. It will identify and apply for in-the-money SPPs and automatically sell the new securities, efficiently recycling your capital into the next SPP. This automatically harvests the discount for SPPs, with minimum capital outlay, low establishment costs and minimal administration.
IPO closed early via OnMarket due to strong investor demand. Please ensure applications are funded by 5pm, 12 April.
EP&T Global Ltd (ASX: EPX) delivers building energy management solutions that reduce energy and water wastage and improve energy efficiency within commercial real estate. The company’s platform, known as EDGE, is a fully integrated Internet of Things (IoT) technology that captures electricity, gas, thermal, water and BMS data and applies analytics to optimise the operational performance of buildings.
Currently providing services to over 280 buildings in 18 countries, EP&T’s clients include a broad range blue chip domestic and international property owners and operators.
Offer closed early via OnMarket due to overwhelming demand.
Hiremii Ltd (ASX: HMI) has two core business components, a fixed fee recruitment business and a recruitment and full-service labour hire business, providing digitised employee onboarding and labour hire. Both businesses utilise a propriety cloud-based platform (Hiremii Platform) which uses machine learning and AI to remove the tedious manual tasks associated with the recruitment and onboarding process, pre-vetting and shortlisting candidates based on employers’ specific requirements.
With 31 registered clients including UGL and PwC Australia, the Company achieved audited sales revenue of ~A$6.2 million for FY2020, growth of 600% over the preceding 12 months.
The QMines Limited IPO has successfully closed. Shares are expected to be allotted early April, with shares expected to be allotted on or around 15 April, with share to begin trading on ASX on Wednesday 21 April.
Island Pharmaceuticals Ltd (ASX: ILA) IPO has successfully closed. The offer was heavily oversubscribed and all applications were scaled back.
Shares are expected to be allotted early April, with shares expected to begin trading on ASX on Tuesday 13 April.
The Sprintex Limited (ASX: SIX) offer has successfully closed raising the full $6.5 million. The company is finalising its approvals with ASX, and the expected ASX relisting date is on or around 8 April 2021.
Singular Health Group Ltd (ASX: SHG) is an Australian based medical technology company focused on the development of medical software for the visualisation, manipulation and transfer of medical imaging data in 3D and virtual reality.
TruScreen Group Limited manufactures and owns all rights to the patented TruScreen Cervical Cancer Screening System. The system uses an AI supported process to detect pre-cancerous and cancerous tissue in real time and is at the forefront of the development of objective opto-electric tissue differentiation.
Now everyone can invest in IPOs. Get ASX IPOs delivered to your inbox. It’s never been easier to get fair, free access to IPOs.
View free digestible, relevant, research and video interviews with company management before deciding what to invest in.
Fast, simple, secure bidding into IPOs either via the OnMarket app or website. Buy shares directly from your phone.
Our performance has motivated members to share OnMarket, earning them over $276,525 in rewards.
The average returns by days post-listing are...
*Based on both open and closed positions of the 150 listed offers as at 1 April 2021.
Performance figures are calculated using a simple average method.